Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Truly amazing
Hormone levels naturally decline with age, and imbalances can lead to symptoms such as fatigue, mood changes, and slowed metabolism
A decrease in A1C, the average blood sugar marker, has been observed in patients taking this category of medications
The primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, improving glycaemic control without causing hypoglycaemia when glucose levels are normal Suppressed glucagon secretion : These agents inhibit inappropriate glucagon release from pancreatic alpha cells, reducing hepatic glucose production Delayed gastric emptying : By slowing the rate at which food leaves the stomach, GLP-1 medications prolong satiety and reduce postprandial glucose excursions Central appetite regulation : GLP-1 receptors in the hypothalamus and brainstem mediate reduced appetite and food intake, leading to decreased caloric consumption Regarding visceral fat specifically, some imaging substudies suggest GLP-1 receptor agonists may reduce visceral adipose tissue alongside subcutaneous fat
US$ 28.01
US$ 27.38
US$ 25.16
US$ 29.13
US$ 22.21
US$ 21.86
